These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 11851400)

  • 1. Characterization of the residues involved in the human alpha-thrombin-haemadin complex: an exosite II-binding inhibitor.
    Richardson JL; Fuentes-Prior P; Sadler JE; Huber R; Bode W
    Biochemistry; 2002 Feb; 41(8):2535-42. PubMed ID: 11851400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystal structure of the human alpha-thrombin-haemadin complex: an exosite II-binding inhibitor.
    Richardson JL; Kröger B; Hoeffken W; Sadler JE; Pereira P; Huber R; Bode W; Fuentes-Prior P
    EMBO J; 2000 Nov; 19(21):5650-60. PubMed ID: 11060016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation, sequence analysis, and cloning of haemadin. An anticoagulant peptide from the Indian leech.
    Strube KH; Kröger B; Bialojan S; Otte M; Dodt J
    J Biol Chem; 1993 Apr; 268(12):8590-5. PubMed ID: 8473305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrostatic steering and ionic tethering in the formation of thrombin-hirudin complexes: the role of the thrombin anion-binding exosite-I.
    Myles T; Le Bonniec BF; Betz A; Stone SR
    Biochemistry; 2001 Apr; 40(16):4972-9. PubMed ID: 11305913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative evaluation of the contribution of ionic interactions to the formation of the thrombin-hirudin complex.
    Stone SR; Dennis S; Hofsteenge J
    Biochemistry; 1989 Aug; 28(17):6857-63. PubMed ID: 2819038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The refined 1.9-A X-ray crystal structure of D-Phe-Pro-Arg chloromethylketone-inhibited human alpha-thrombin: structure analysis, overall structure, electrostatic properties, detailed active-site geometry, and structure-function relationships.
    Bode W; Turk D; Karshikov A
    Protein Sci; 1992 Apr; 1(4):426-71. PubMed ID: 1304349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Basis for the reduced affinity of beta T- and gamma T-thrombin for hirudin.
    Stone SR; Hofsteenge J
    Biochemistry; 1991 Apr; 30(16):3950-5. PubMed ID: 2018764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of regions of alpha-thrombin involved in its interaction with hirudin.
    Stone SR; Braun PJ; Hofsteenge J
    Biochemistry; 1987 Jul; 26(15):4617-24. PubMed ID: 3663613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anophelin: kinetics and mechanism of thrombin inhibition.
    Francischetti IM; Valenzuela JG; Ribeiro JM
    Biochemistry; 1999 Dec; 38(50):16678-85. PubMed ID: 10600131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The isomorphous structures of prethrombin2, hirugen-, and PPACK-thrombin: changes accompanying activation and exosite binding to thrombin.
    Vijayalakshmi J; Padmanabhan KP; Mann KG; Tulinsky A
    Protein Sci; 1994 Dec; 3(12):2254-71. PubMed ID: 7756983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bifunctional peptide boronate inhibitors of thrombin: crystallographic analysis of inhibition enhanced by linkage to an exosite 1 binding peptide.
    Skordalakes E; Elgendy S; Goodwin CA; Green D; Scully MF; Kakkar VV; Freyssinet JM; Dodson G; Deadman JJ
    Biochemistry; 1998 Oct; 37(41):14420-7. PubMed ID: 9772168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ionic interactions in the formation of the thrombin-hirudin complex.
    Betz A; Hofsteenge J; Stone SR
    Biochem J; 1991 May; 275 ( Pt 3)(Pt 3):801-3. PubMed ID: 1674862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure of the complex of the antistasin-type inhibitor bdellastasin with trypsin and modelling of the bdellastasin-microplasmin system.
    Rester U; Bode W; Moser M; Parry MA; Huber R; Auerswald E
    J Mol Biol; 1999 Oct; 293(1):93-106. PubMed ID: 10512718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mapping of the thrombin des-ETW conformation by using site-directed mutants of hirudin. Evidence for the induction of nonlocal modifications by mutagenesis.
    Le Bonniec BF; Betz A; Guinto ER; Esmon CT; Stone SR
    Biochemistry; 1994 Apr; 33(13):3959-66. PubMed ID: 8142400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new structural class of serine protease inhibitors revealed by the structure of the hirustasin-kallikrein complex.
    Mittl PR; Di Marco S; Fendrich G; Pohlig G; Heim J; Sommerhoff C; Fritz H; Priestle JP; Grütter MG
    Structure; 1997 Feb; 5(2):253-64. PubMed ID: 9032072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular mapping of the heparin-binding exosite of thrombin.
    Sheehan JP; Sadler JE
    Proc Natl Acad Sci U S A; 1994 Jun; 91(12):5518-22. PubMed ID: 8202520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The structure of alpha-thrombin inhibited by a 15-mer single-stranded DNA aptamer.
    Padmanabhan K; Padmanabhan KP; Ferrara JD; Sadler JE; Tulinsky A
    J Biol Chem; 1993 Aug; 268(24):17651-4. PubMed ID: 8102368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in interactions in complexes of hirudin derivatives and human alpha-thrombin due to different crystal forms.
    Priestle JP; Rahuel J; Rink H; Tones M; Grütter MG
    Protein Sci; 1993 Oct; 2(10):1630-42. PubMed ID: 8251938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ornithodorin-thrombin crystal structure, a key to the TAP enigma?
    van de Locht A; Stubbs MT; Bode W; Friedrich T; Bollschweiler C; Höffken W; Huber R
    EMBO J; 1996 Nov; 15(22):6011-7. PubMed ID: 8947023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leech-derived thrombin inhibitors: from structures to mechanisms to clinical applications.
    Corral-Rodríguez MA; Macedo-Ribeiro S; Pereira PJ; Fuentes-Prior P
    J Med Chem; 2010 May; 53(10):3847-61. PubMed ID: 20155915
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.